EVAX Evaxion

NEUTRAL Impact: 3/10 PRESS-RELEASE
Horizon days Filed Mar 2, 2026 Processed 3mo ago Wire GlobeNewswire
Press release: announcement
Final — all horizons settled through T+60d
EVAX ▲ +29.65% at T+60d
NEUTRAL call ✓ call won +29.65% · α vs SPY +20.33% · entry $3.17 → $4.11
Last close $3.64 (close Jun 12) · +14.83% from $3.17 entry
Entry anchored
Feb 27, 03:59 PM ET
via Databento tick
T+1d
-1.58%
call -1.58% · α -0.66%
$3.12
settled 3mo ago
T+5d
-2.84%
call -2.84% · α -1.63%
$3.08
settled 3mo ago
T+20d
+18.93%
call +18.93% · α +26.87%
$3.77
settled 3mo ago
T+60d
+29.65%
call +29.65% · α +20.33%
$4.11
settled 19d ago

Price Chart

Loading chart...

Executive Summary

Evaxion announced it will release its full-year 2025 financial results and provide a business update on March 5, 2026, followed by a conference call. The press release contains no financial data or material operational updates, only logistical details for the upcoming earnings event.

Actionable Insight

Traders should prepare for potential volatility following the March 5 earnings release. Monitor the upcoming financial results for revenue, cash runway, and R&D spend, which will be critical for assessing the company's development trajectory.

Key Facts

  • Evaxion will report full-year 2025 financial results on March 5, 2026, before Nasdaq opens.
  • Management will host a conference call and webcast the same day at 08:30 EST / 14:30 CET.
  • No financial results, guidance, or material business updates were disclosed in this announcement.
  • The release includes forward-looking statements and risk disclosures typical of public biotech companies.

Financial Impact

No financial impact from this announcement alone — no data disclosed.

Risk Factors

  • Low liquidity and high volatility risk due to small market cap ($26M).
  • Forward-looking statements suggest significant risks around funding, clinical development, and regulatory pathways.
  • No financials or updates provided — actual results could surprise to the upside or downside.

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3247291
23 reports for EVAX
Performance horizon
100% Hit rate 6 of 6 directional calls best @ T+5▲ +22.94%Mar 5, 2026
Filters
Rows
Reports for EVAX — sortable, filterable
Type Now
Jun 12, 2026
2d ago
6-K
NEUTRAL ★ 3/10
$3.71 awaiting T+5awaiting T+5$3.64 (−1.89%)
Jun 12, 2026
3d ago
Press Release
NEUTRAL ★ 3/10
$3.71 awaiting T+5awaiting T+5$3.64 (−1.89%)
Jun 11, 2026
3d ago
6-K
BULLISH ★ 6/10
$3.72 awaiting T+5awaiting T+5$3.64 (−2.15%)
Jun 11, 2026
4d ago
Press Release
NEUTRAL ★ 4/10
$3.72 awaiting T+5awaiting T+5$3.64 (−2.15%)
May 12, 2026
4w ago
6-K
NEUTRAL ★ 3/10
$4.17 $4.09▼ −1.92%▼ −2.00%$3.64 (−12.71%)
May 12, 2026
4w ago
Press Release
NEUTRAL ★ 4/10
$4.17 $4.09▼ −1.92%▼ −2.00%$3.64 (−12.71%)
May 7, 2026
5w ago
6-K
NEUTRAL ★ 3/10
$4.07 $4.16▲ +2.21%▲ +0.71%$3.64 (−10.57%)
May 4, 2026
5w ago
Press Release
NEUTRAL ★ 1/10
$4.57 $4.23▼ −7.55%▼ −10.49%$3.64 (−20.35%)
Apr 27, 2026
6w ago
6-K
NEUTRAL ★ 3/10
$4.18 $4.57▲ +9.33%▲ +8.93%$3.64 (−12.92%)
Apr 27, 2026
6w ago
Press Release
NEUTRAL ★ 3/10
$4.18 $4.57▲ +9.33%▲ +8.93%$3.64 (−12.92%)
Showing 10 of 23

US Market Status

Market Closed — Opens in 5h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access